头颈部肿瘤中通过概率治疗计划将患者几何变异纳入自适应计划优化的剂量学评估
该计划研究对18例头颈部肿瘤患者回顾性生成4种策略计划:仅图像引导放疗(IGRT-only)、3毫米和0毫米计划靶区(PTV)边界的两种传统自适应计划、以及4D自适应放疗(4D ART)。4D ART在靶区覆盖和危及器官保护之间取得更好平衡,正常组织并发症概率(NTCP)模型预测其较IGRT-only可使部分患者获得临床获益,但需进一步临床验证。
要点
- 3毫米PTV边界自适应计划使危及器官平均剂量较IGRT-only降低1至2 Gy。
- 0毫米自适应计划进一步降低危及器官剂量2至3 Gy,但以靶区覆盖为代价。
- 4D ART改善靶区覆盖并达到与0毫米自适应计划相似的危及器官保护。
核心结论
- 与基于边界的自适应计划策略相比,4D ART在靶区覆盖和危及器官保护之间提供了更好的平衡。
- NTCP估算预测了理论上的临床获益,但需进一步临床验证。
研究设计与样本
- 对18例头颈部肿瘤患者回顾性生成4种策略的治疗计划:仅IGRT策略、使用3毫米和0毫米PTV边界的两种传统自适应计划策略、以及4D ART策略。
- IGRT-only策略全程使用常规3毫米PTV边界治疗计划;两种传统自适应策略在第10次和第22次分次后基于诊断性计划CT生成2个新计划。
- 4D ART遵循相同自适应时间表,但使用最近5次治疗分次中采集的5幅锥形束CT(CBCT)图像生成4D自适应计划。
- 每种策略的实际总疗程剂量通过在35幅CBCT扫描上计算每日剂量、形变回治疗前计划CT并累积全部35次分次构建。
主要发现
- 3毫米PTV边界时,无论是否自适应,原发临床靶区(CTV1)和 elective 淋巴结临床靶区(CTV2)均达到足够靶区覆盖。
- 3毫米自适应计划较IGRT-only计划使危及器官平均剂量降低1至2 Gy。
- 0毫米自适应计划进一步使危及器官剂量降低2至3 Gy,但CTV1和CTV2分别有3例和1例患者V100%<95%,分别有6例和5例患者D99剂量不足>2 Gy。
- 4D ART改善靶区覆盖并达到与0毫米自适应计划相似的危及器官保护,CTV1和CTV2的V100%<95%患者数分别降至0例和0例,D99剂量不足>2 Gy患者数分别降至0例和2例。
- NTCP计算提示4D ART较IGRT-only可使相当部分患者获益:腮腺毒性方面分别有17例和12例患者NTCP降低≥5%和≥10%,吞咽毒性方面分别有18例和3例患者NTCP降低≥5%和≥10%。
关键数值与推荐
- 靶区覆盖足够定义为V100%≥95%且D99剂量不足≤2 Gy(相对于处方剂量)。
- 靶区覆盖评估使用接受≥100%处方剂量的靶区体积百分比(V100%)和99%靶区体积的最小剂量(D99)。
- NTCP值使用3种NTCP模型计算。
临床怎么用
- 原文未据此给出推荐。
局限性
- NTCP估算预测的理论临床获益需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Four-dimensional (4D) adaptive radiation therapy (ART) treatment planning is an alternative to the conventional margin-based treatment planning approach. In 4D ART, interfraction patient geometric variations, gathered from computed tomography (CT) or cone beam CT (CBCT) images acquired during the patient treatment course, are directly incorporated into the adaptive plan optimization using a probabilistic treatment planning method. The goal of the present planning study was to evaluate the dosimetric differences between 4D ART and conventional margin-based adaptive planning strategies for head and neck cancers. In addition, we examined whether the dose differences achieved with 4D ART would translate into clinically relevant toxicity reductions using the existing normal tissue complication probability (NTCP) models. METHODS AND MATERIALS: For 18 head and neck cancer patients, the treatment plans were retrospectively generated for 4 different treatment strategies, including a solely image guided radiation therapy (IGRT) strategy (IGRT-only), 2 conventional adaptive treatment planning strategies using 3- and 0-mm planning target volume (PTV) margins, and the 4D ART strategy. In the IGRT-only strategy, a conventional 3-mm PTV margin treatment plan was applied for the entire treatment course. In the 2 conventional adaptive strategies, 2 new treatment plans were generated during the treatment course using diagnostic planning CT scans acquired after the 10th and 22nd fractions. The 4D ART followed the same adaptive schedule, except that the 4D adaptive plan was generated using 5 CBCT images acquired during the 5 most recent treatment fractions. For each strategy, the actual delivered dose for the entire treatment course was constructed by calculating the daily doses on 35 CBCT scans, deforming back to the pretreatment planning CT scan, and accumulating over all 35 fractions. The target coverage was evaluated using the percentage of target volume receiving ≥100% of the prescription dose (V100%) and the minimum dose to 99% of the target volume (D99). It was considered adequate if the V100% was ≥95% and the dose deficit in D99 was ≤2 Gy (with respect to the prescription dose). For each strategy, the dose received by the organs at risk (OARs) was also evaluated, and the corresponding NTCP values were subsequently calculated using 3 NTCP models. RESULTS: Adequate target coverage was achieved for the primary clinical target volume (CTV1) and elective nodal CTV (CTV2) with a 3-mm PTV margin, regardless of adaptation. The 3-mm ART plan reduced the OAR mean dose by 1 to 2 Gy compared with the IGRT-only plan. The 0-mm ART plan further reduced the OAR dose by another 2 to 3 Gy at the expense of target coverage: 3 and 1 patient had V100% <95%, and 6 and 5 patients had a >2 Gy dose deficit in D99 for the CTV1 and CTV2, respectively. Use of 4D ART improved target coverage and attained OAR sparing similar to that with 0-mm ART. The number of patients with V100% <95% and >2 Gy D99 deficit decreased to 0 and 0 for CTV1 and 0 and 2 for CTV2, respectively. The NTCP calculations suggested that 4D ART could benefit a substantial portion of patients compared with IGRT-only because 17 and 12 patients had ≥5% and ≥10% NTCP reductions for parotid toxicity and 18 and 3 patients had ≥5% and ≥10% NTCP reductions for swallowing toxicity, respectively. CONCLUSIONS: Compared with margin-based adaptive planning strategies, 4D ART provides a better balance between target coverage and OAR sparing. NTCP estimation predicted for theoretical clinical benefits that warrant further clinical validation.
引用
- Liu Q, Liang J, Zhou D, et al. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers. Int J Radiat Oncol Biol Phys. 2018. PMID: 29976511. doi:10.1016/j.ijrobp.2018.03.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。